Delving into the Latest Updates on Genistein Capsule with Synapse

Overview

Basic Info

Drug Type

Herbal medicine

Synonyms-

Target

CB1R

Action

antagonists

Mechanism

CB1 antagonists(Cannabinoid CB1 receptor antagonists)

Therapeutic Areas

Endocrinology and Metabolic DiseaseSkin and Musculoskeletal Diseases

Active Indication-

Inactive Indication

Osteoporosis

Originator Organization-

Active Organization-

Inactive Organization

Institute of Materia Medica, Fourth Military Medical University of the Chinese People's Liberation ArmyXian Hengtai Herbal Technology Co. Ltd.

Drug Highest PhasePendingPhase 2

First Approval Date-

Regulation-

Login to view timeline

The single-dose human pharmacokinetics of genistein capsules in healthy subjects and the pharmacokinetics in the fed state were studied to observe the effect of food on drug absorption, so as to provide a scientific basis for the formulation of the medication plan for Phase II clinical trials and the rational use of drugs in clinical practice.

Start Date01 Jun 2006

Sponsor / Collaborator

Xian Hengtai Herbal Technology Co. Ltd.

[+1]

100 Clinical Results associated with Genistein Capsule

Login to view more data

100 Translational Medicine associated with Genistein Capsule

Login to view more data

100 Patents (Medical) associated with Genistein Capsule

Login to view more data

100 Deals associated with Genistein Capsule

Login to view more data

R&D Status

10 top R&D records.

Login

to view more data

Indication	Highest Phase	Country/Location	Organization	Date
Osteoporosis	Phase 2	China	Institute of Materia Medica, Fourth Military Medical University of the Chinese People's Liberation Army	24 Aug 2015
Osteoporosis	Phase 2	China	Xian Hengtai Herbal Technology Co. Ltd.	24 Aug 2015